PUBLISHER: The Business Research Company | PRODUCT CODE: 1942619
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942619
Corneal implants involve a surgical intervention aimed at either replacing or enhancing a damaged or diseased cornea through the integration of an artificial or prosthetic device. This procedure is carried out to address visual impairments and alleviate associated pain.
The two primary categories of corneal implants are artificial corneal implants and human corneal implants. Artificial corneal implants are medical devices specifically designed to substitute a damaged or diseased cornea. Various techniques, such as endothelial keratoplasty and penetrating keratoplasty, are employed for corneal implants. These procedures serve diverse applications, including addressing conditions such as keratoconus, Fuchs dystrophy, infectious keratitis, corneal ulcers, among others. The implementation of corneal implant procedures typically takes place in medical facilities such as hospitals and ophthalmic centers.
Tariffs are impacting the corneal implants market by increasing costs of imported biomaterials, surgical instruments, preservation media, and precision manufacturing components. Ophthalmic centers in North America and Europe are most affected due to reliance on imported implants and surgical supplies, while Asia-Pacific faces higher costs in implant manufacturing and distribution. These tariffs are raising procedure costs and affecting accessibility. However, they are also encouraging localized implant production, regional tissue banking initiatives, and innovation in synthetic corneal implant development.
The corneal implants market research report is one of a series of new reports from The Business Research Company that provides corneal implants market statistics, including corneal implants industry global market size, regional shares, competitors with a corneal implants market share, detailed corneal implants market segments, market trends and opportunities, and any further data you may need to thrive in the corneal implants industry. This corneal implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The corneal implants market size has grown strongly in recent years. It will grow from $1.42 billion in 2025 to $1.51 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing prevalence of corneal disorders, expansion of ophthalmic surgical capabilities, availability of donor corneas, rising awareness of vision correction options, improvements in surgical instrumentation.
The corneal implants market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing investments in regenerative ophthalmology, rising demand for vision restoration procedures, expansion of advanced eye care facilities, growing adoption of bioengineered implants, increasing focus on long-term implant durability. Major trends in the forecast period include increasing adoption of artificial corneal implants, rising use of advanced keratoplasty techniques, growing focus on biocompatible implant materials, expansion of specialized ophthalmic surgical centers, enhanced precision in corneal transplant procedures.
The anticipated rise in the prevalence of corneal disorders is poised to drive the expansion of the corneal implant market in the coming years. Corneal disorders encompass a range of medical conditions affecting the cornea, the clear, dome-shaped front surface of the eye, leading to visual impairment and discomfort. The growing incidence of corneal disorders has resulted in an increased demand for corneal implants, offering diverse solutions for treating corneal abnormalities, enhancing corneal integrity, alleviating symptoms, and improving vision. As an example, data from the Center for Disease Control (CDC) in December 2022 revealed that in the United States, the prevalence of cataracts (a corneal disorder) among individuals aged over 40 is estimated at 20.5 million, constituting approximately 17.2% of the population in that age group. Moreover, this figure is projected to surpass 30 million by the year 2028. Consequently, the upsurge in corneal disorders is a key driver for the growth of the corneal implant market.
Major companies in the corneal implants market are concentrating on developing innovative corneal contouring solutions to enhance vision correction and treat various corneal disorders. These solutions involve advanced surgical techniques and devices aimed at reshaping the cornea to improve vision and address refractive errors or corneal diseases. For instance, in June 2024, CorneaGen, a US-based developer of medical devices focused on eliminating corneal blindness, launched the Corneal Tissue Addition for Keratoplasty (CTAK). This innovative solution offers a highly effective approach to corneal contouring for keratoconic eyes. The CTAK technique involves adding donor corneal tissue to the existing cornea instead of completely replacing it. This method aims to restore the natural contour of the cornea, thereby enhancing optical clarity and improving overall visual outcomes for patients.
In January 2023, Viatris Inc., a US-based pharmaceutical and healthcare corporation, completed the acquisitions of Oyster Point Pharma and Family Life Sciences for $415 million and $280 million, respectively. Through these acquisitions, Viatris Inc. aims to expand its commercial presence and portfolio, positioning itself as a global leader in eye care, and addressing the unmet needs of patients with ophthalmic diseases and eye care professionals. Oyster Point Pharma, a US biopharmaceutical company, specializes in identifying, developing, and marketing novel treatments for eye diseases, while Family Life Sciences, an Indian drug development platform, specializes in ophthalmology.
Major companies operating in the corneal implants market are Alcon Inc., Bausch & Lomb Incorporated, Johnson & Johnson Vision, ZEISS Group, AJL Ophthalmic SA, CorNeat Vision Ltd., EyeYon Medical Ltd., Precise Bio Inc., CorneaGen, Cornea Biosciences LLC, Linkocare Life Sciences AB, MediPhacos, Coroneo Pty Ltd., KeraMed Inc., DIOPTEX Co. Ltd., HumanOptics AG, Morcher GmbH, Moria SA, DORC International BV, Aurolab (Aravind Eye Care System)
North America was the largest region in the cornea implants market in 2025. Asia Pacific is expected to be the fastest-growing region in the global cornea implants market during the forecast period. The regions covered in the corneal implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the corneal implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The corneal implants market includes revenues earned by entities by providing corneal implantation services, including deep anterior lamellar keratoplasty (DALK) and Descemet rhexis without endothelial keratoplasty (DWEK). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Corneal Implants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses corneal implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for corneal implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The corneal implants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.